Holly Holliday is a cell and molecular biologist specialising in epigenetics, gene regulation, and paediatric cancer. She completed her Bachelor of Medical Science with a Biochemistry major at the University of Sydney in 2014 and obtained her PhD from the Garvan Institute, where she studied transcriptional regulation of mammary gland development. She has conducted postdoctoral research on microRNAs in neuroblastoma at the Garvan Institute, and currently works as a senior postdoc in the Brain Tumour group at the Children’s Cancer Institute, investigating epigenetic targeted therapies for Diffuse Midline Glioma..